(28 days)
Not Found
Not Found
No
The description mentions signal processing techniques to compensate for patient motion, which is a common digital signal processing method and does not necessarily imply AI/ML. There are no explicit mentions of AI, ML, or related terms, nor is there any description of training or test data sets typically associated with AI/ML development.
No
The device is described as a "portable patient monitor" intended for "monitoring vital signs." Its function is entirely about observation and measurement, not treatment or intervention to restore health.
Yes
The device is intended for "monitoring vital signs of critically ill adult, pediatric and neonatal patients." Monitoring vital signs is a diagnostic function, as it provides information about a patient's health status.
No
The device description explicitly states it is a "portable patient monitor" and describes modifications to the "Pulse Oximeter (SpO2) options," which are hardware components.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to monitor vital signs of patients in the hospital environment. This involves monitoring physiological parameters directly from the patient, not analyzing samples taken from the patient outside of the body.
- Device Description: The device is a patient monitor that measures vital signs like Pulse Oximetry (SpO2). This is a direct measurement from the patient's body.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.) or performing tests on these samples in vitro (outside the living organism).
IVD devices are specifically designed to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This device does not fit that description.
N/A
Intended Use / Indications for Use
The Medical Data Electronics ESCORT II+ 400 Series Monitor is a portable patient monitor intended to be used for monitoring vital signs of critically ill adult, pediatric and neonatal patients in the hospital environment.
Product codes
DQA
Device Description
The modified ESCORT II+ 400 Series (ESCORT Prism) monitor is Device identical to the to the currently marketed device with the exception of the functionality of the Pulse Oximeter (SpO2) options available. The predicate device, incorporating Nellcor MP204 technology, does not predicate de id signal processing techniques to compensate for patient motion. The modified device, incorporating Nellcor MP405 technology, incorporates features to compensate for patient motion.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Adult, pediatric and neonatal patients
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Testing of the modified ESCORT II+ 400 Series (ESCORT Prism) Testing Testing of the modieted by MDE to ensure mitigation of hazards. V&V monitors was conduction of the modified device to safety standards are the same as those conducted on the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2700 Oximeter.
(a)
Identification. An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.(b)
Classification. Class II (performance standards).
0
JAN 2 5 2002
ATTACHMENT 4
510(k) Summary
December 27, 2001 Date
- Greg Alkire Contact Director, Regulatory Affairs Medical Data Electronics 12720 Wentworth Street Arleta, California 91331 818-768-6411 Telephone: Telefax: 818-768-4197 Email: Galkire@emailmde.com
ESCORT II+ 400 Series (ESCORT Prism) Monitor
Device Name
- Patient Monitor, Vital Signs Monitor Common May Include Options: Name Carbon Dioxide Analyzer Cardiac Monitor Cardiac Output Computer Breathing Frequency Monitor Recorder Invasive Blood Pressure RF Physiological Transmitter/Receiver Temperature Defibrillator Noninvasive Blood Pressure External Pacer Pulse Oximetry
- Classification The classification names and classifications of the Options available for the ESCORT II+ 400 Series (ESCORT Prism) monitors are as follows:
| Option | Classification
Number | Class |
|---------------------------------------|--------------------------|-------|
| Cardiac Monitor | 870.2300 | II |
| Breathing Frequency Monitor | 868.2375 | II |
| Invasive Blood Pressure | 870.1110 | II |
| Temperature | 880.2910 | II |
| Noninvasive Blood Pressure | 870.1130 | II |
| Pulse Oximetry | 870.2700 | II |
| Carbon Dioxide Analyzer | 868.1400 | II |
| Cardiac Output Computer | 870.1435 | 11 |
| Recorder | 870.2810 | II |
| RF Physiological Transmitter/Receiver | 870.2910 | 11 |
| | 870.5300 | 11 |
| Defibrillator
External Pacer | 870.3600 | II |
The ESCORT Prism monitor is classified as a Class II Device.
1
ESCORT II+ 400 Series (ESCORT Prism) Monitor Predicate Device
The modified ESCORT II+ 400 Series (ESCORT Prism) monitor is Device identical to the to the currently marketed device with the exception of the Description functionality of the Pulse Oximeter (SpO2) options available. The predicate device, incorporating Nellcor MP204 technology, does not predicate de id signal processing techniques to compensate for patient motion. The modified device, incorporating Nellcor MP405 technology, incorporates features to compensate for patient motion.
The Medical Data Electronics ESCORT II+ 400 Series Monitor is a Indications The Medical Datient monitor intended to be used for monitoring vital signs of For Use critically ill adult, pediatric and neonatal patients in the hospital environment.
Technological The modified ESCORT II+ 400 Series (ESCORT Prism) has the same I echnological The mountied 25 secteristics as the predicate device with the exception of the type of signal processing utilized for pulse oxygen saturation and pulse rate information incorporated in the modified device.
Testing of the modified ESCORT II+ 400 Series (ESCORT Prism) Testing Testing of the modieted by MDE to ensure mitigation of hazards. V&V monitors was conduction of the modified device to safety standards are the same as those conducted on the predicate device.
Medical Data Electronics, in accordance with the FFDCA and 21 CFR Conclusions Part 807 and data included in this premarket notification, concludes that i art 601 and addid 100 Series (ESCORT Prism) Monitor is safe, effective and substantially equivalent to the predicate device.
ู้
2
Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health and Human Services. The logo features a stylized caduceus, a symbol often associated with medicine and healthcare, with a double helix-like design. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the caduceus.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JAN 2 5 2002
Mr. Greg Alkire Medical Data Electronics, Inc. 12723 Wentworth Street Arleta, CA 91331
Re: K014294
ESCORT II+ 400 Series (ESCORT Prism) Monitor Regulation Number: 870.2700 Regulation Name: Oximeter Regulatory Class: Class II (two) Product Code: DQA Dated: December 26, 2001 Received: December 28, 2001
Dear Mr. Alkire:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. In addition, if you wish to change or expand the current indications for use to include non-military environments, you will need to submit a new 510(k) premarket notification, and receive FDA clearance prior to marketing the device.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Mr. Greg Alkire
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
V. Parker Tull
Bram D. Zuckerman, M.D. Acting Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
ATTACHMENT 2
Indications for Use Statement
Page 1 of
510(k) Number (if known): __
Device Name: ESCORT II+ 400 Series (ESCORT Prism) Monitor
Indications for Use:
The Medical Data Electronics ESCORT II+ 400 Series Monitor is a portable patient moritor intended to be used for monitoring vital signs of critically ill adult, pediatric and neonatal patients in the hospital environment.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Division of Cardiovascular & Respiratory Devices
510(k) Number K014294
Prescription Use √
(Per 21 CFR 801.109)
OR
Over-the-Counter Use__________________________________________________________________________________________________________________________________________________________
(Optional Format 1-2-96)
28